BackGreenLight Biosciences Overview

GreenLight Biosciences Receivables

GreenLight Biosciences's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-5.00M vs prior year quarter

Peer trimmed avg / median

Loading

GreenLight Biosciences Receivables History

Loading

GreenLight Biosciences vs. peers: Receivables Comparison

Loading

GreenLight Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GreenLight Biosciences (GRNA) FAQ

As of the most recent data (March 2023), GRNA shows a receivables of $0. That compares with $5M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNA's receivables is now $0 (was $5M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences is outperforming or lagging.

Tracking GRNA's receivables over time shows whether GreenLight Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $5M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has GreenLight Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.